Exane Derivatives’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Exane Derivatives’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-22,524	Closed	-$137K	–	1122
2021 Q3	$137K	Buy	22,524 +22,271	+8,803%	+$139K	0.03%	481
2021 Q2	$1.82K	Hold	253	–	–	﹤0.01%	824
2021 Q1	$2.26K	Sell	253 -10,192	-98%	-$117K	﹤0.01%	672
2020 Q4	$121K	Buy	+10,445	New	+$121K	0.04%	372

Exane Derivatives's FLXN Position: Q4 2021 in Review

Exane Derivatives sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 22,524 shares — an estimated $137K sold.

Exane Derivatives first reported a position in FLXN in Q4 2020 and held it in 4 quarters. The position peaked at $137K in Q3 2021. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.

Exane Derivatives reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
Exane Derivatives sold 22,524 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $137K.
Exane Derivatives first reported a position in Flexion Therapeutics, Inc. in Q4 2020 and held it in 4 quarters.
Exane Derivatives's Flexion Therapeutics, Inc. position peaked at $137K in Q3 2021.
1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.

Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.